Katriina Annunen's Master's Thesis on Digi-HTA and Medical Device Regulation

Our QA/RA Specialist Katriina Annunen has graduated from her Master's in Well-being Digital Service Expertise finalizing her studies with an interesting thesis titled "Added Value that Digi-HTA Assessment Brings to Digital Health Technology Products Compared to the Requirements of the Medical Device Regulation".
Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) has developed an assessment method called Digi-HTA. This assessment method is meant for digital health technologies (DHTs) and to support the introduction of novel technologies into Finnish healthcare. There are several national HTA processes developed in the EU and more harmonized approach is in need also.
The aim of Annunen's thesis was to identify differences and similarities between the Digi-HTA assessment method and the medical device regulation 2017/745/EU. The purpose was to clarify the roles of the Digi-HTA assessments and the medical device regulation and to identify possible areas for development of Digi-HTA assessment. Requirements for medical devices are strict and the role of Digi-HTA in this context is unclear. The study was comparing these two and found out that there is no significant overlap, though Digi-HTA assessment could be partially simplified for medical devices. Digi-HTA assessment could help device manufacturers still in the product development phase to produce higher quality and facilitate the decision-making of healthcare providers.
You can access the study here: https://www.theseus.fi/handle/10024/788648
Visit us
Contact us
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
Cerenion Oy
Elektroniikkatie 3
90590 Oulu
Cerenion Oy
Kyllikinportti 2
00240 Helsinki
Call us: +358 50 447 4909
E-mail us:
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.
Powered by:MetaVisual CMSMobile versionDesktop versionLog in© 2017 - 2023 Cerenion Oy